Apoptosis and cancer drug targeting.
Sellers
W R
WR
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. William_Sellers@dfci.harvard.edu
Fisher
D E
DE
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000378:metabolism; D016158:Genes, p53; D006801:Humans; D016328:NF-kappa B / Q000187:drug effects / Q000502:physiology; D019869:Phosphatidylinositol 3-Kinases / Q000187:drug effects / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000187:drug effects / Q000502:physiology; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt
D000970:Antineoplastic Agents; D020169:Caspases; D016328:NF-kappa B; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt